Browsing: Medication & Drugs

Semaglutide (Rybelsus®) receives FDA approval as first line treatment for Type 2 Diabetes Mellitus

By ShanPingApril 7, 20230

Semaglutide, available in oral and subcutaneous dosage forms, is a selective glucagon-like peptide-1 receptor agonist with 3 main mechanisms of action.

Contaminated Eye Drops Linked to Vision Loss and Death

By Gerald NgMarch 24, 20230

The article discusses the rising death toll and vision loss linked to contaminated eye drops in the United States. More than 10 brands of artificial tears have been recalled, with most cases being linked to EzriCare and Delsam Pharma eye drops made by India-based Global Pharma Healthcare.

“Miracle” Skin Cream Ruxolitinib to Cure Vitiligo Could be Made Available Soon

By Saba KashMarch 9, 20230

A drug called ruxolitinib, which has been touted as a “miracle” cream, has shown promise in treating vitiligo. Read more

FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

By KayeJanuary 20, 20230

In Dec 2022, the FDA approved BRIUMVI™, a chimeric monoclonal antibody (mAb) labelled for the treatment of RMS

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

By KayeJanuary 13, 20230

Lenacapavir (Sunleca®), a first-in-class long-acting HIV-1 capsid function inhibitor, was approved by the FDA in December 2022

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

By MCA TeamDecember 9, 20220

InnoCare Pharma announced the approval of HIBRUKA (Orelabrutinib) by the HSA of Singapore for the treatment of adult patients with r/r MCL

An Introduction to Drug Allergies

By Alyssa YapNovember 15, 20220

Medication use is associated with the risk for adverse drug reactions (ADRs). This article will focus on one of them.

A Summary of Pharmacotherapies for Smoking Cessation

By ShanPingNovember 3, 20220

An Overview on Antibiotics

By Alyssa YapOctober 28, 20221

Antibiotics can prevent and treat certain infections. Several types of antibiotics exist, find out more in this article.

Evidence for Smoking Cessation after Cardiovascular Events – Part 1

By ShanPingOctober 26, 20220

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Grateful, But Still Not Free From Haemophilia

How an Automated 3D Breast Ultrasound System Is Changing Imaging Workflows

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Browsing: Medication & Drugs

Semaglutide (Rybelsus®) receives FDA approval as first line treatment for Type 2 Diabetes Mellitus

Contaminated Eye Drops Linked to Vision Loss and Death

“Miracle” Skin Cream Ruxolitinib to Cure Vitiligo Could be Made Available Soon

FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

Breakthrough Therapy: What You Need to Know about HIBRUKA (Orelabrutinib)

An Introduction to Drug Allergies

A Summary of Pharmacotherapies for Smoking Cessation

An Overview on Antibiotics

Evidence for Smoking Cessation after Cardiovascular Events – Part 1

Grateful, But Still Not Free From Haemophilia

How an Automated 3D Breast Ultrasound System Is Changing Imaging Workflows

Prof Poh Kian Keong is Singapore’s Only Recipient of the American College of Cardiology’s 2026 Distinguished Awards

Can You Survive a Week on Instant Noodles Alone?

Subscribe to Updates

What's Hot

Browsing: Medication & Drugs

Subscribe to Updates